Clovis Oncology downgraded by H.C. Wainwright
$CLVS
Biotechnology: Pharmaceutical Preparations
Health Care
H.C. Wainwright downgraded Clovis Oncology from Buy to Neutral
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/6/2022 | Buy → Neutral | H.C. Wainwright | |
| 9/21/2021 | $10.00 → $9.00 | Buy | HC Wainwright & Co. |
| 8/5/2021 | $12.00 → $10.00 | Buy | HC Wainwright & Co. |
4 - Clovis Oncology, Inc. (0001466301) (Issuer)
4 - Clovis Oncology, Inc. (0001466301) (Issuer)
4 - Clovis Oncology, Inc. (0001466301) (Issuer)
EFFECT - Clovis Oncology, Inc. (0001466301) (Filer)
15-12G - Clovis Oncology, Inc. (0001466301) (Filer)
S-8 POS - Clovis Oncology, Inc. (0001466301) (Filer)